Trial Profile

A Phase 2 SSc program for CM-101

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 24 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CM 101 (Primary)
Indications Systemic scleroderma
Focus Therapeutic Use

Most Recent Events

24 Apr 2024 New trial record
18 Apr 2024 Chemomab Therapeutics media release, company has a Phase 2-ready SSc program with an open US IND, with possible initiation of patient enrollment after the topline readout from Phase 2 trial in primary sclerosing cholangitis that is expected in the next few months.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com